Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 USD | +2.80% | -4.56% | +35.80% |
20/03 | Canaccord Genuity Adjusts Price Target on Tenaya Therapeutics to $18 From $19, Maintains Buy Rating | MT |
19/03 | North American Morning Briefing : Stock Futures -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+35.80% | 34Cr | |
+29.03% | 4.82TCr | |
-0.10% | 4.17TCr | |
+43.45% | 4.1TCr | |
-5.26% | 2.88TCr | |
+11.48% | 2.56TCr | |
-22.74% | 1.9TCr | |
+9.06% | 1.29TCr | |
+30.01% | 1.2TCr | |
-1.51% | 1.18TCr |
- Stock Market
- Equities
- TNYA Stock
- News Tenaya Therapeutics, Inc.
- Tenaya Therapeutics Doses First Patient in Early Stage Trial of Heart Disease Gene Therapy Candidate